|
1.
|
Lee MW, Kim DS, Min NY and Kim HT: Akt1
inhibition by RNA interference sensitizes human non-small cell lung
cancer cells to cisplatin. Int J Cancer. 122:2380–2384. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Takenaka T, Yoshino I, Kouso H, Ohba T,
Yohena T, Osoegawa A, Shoji F and Maehara Y: Combined evaluation of
Rad51 and ERCC1 expressions for sensitivity to platinum agents in
non-small cell lung cancer. Int J Cancer. 121:895–900. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Machado-Silva A, Perrier S and Bourdon JC:
p53 family members in cancer diagnosis and treatment. Semin Cancer
Biol. 20:57–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Vayssade M, Haddada H, Faridoni-Laurens L,
Tourpin S, Valent A, Bénard J and Ahomadegbe JC: p73 functionally
replaces p53 in Adriamycin-treated, p53-deficient breast cancer
cells. Int J Cancer. 116:860–869. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Leong CO, Vidnovic N, De Young MP, Sgroi D
and Ellison L: The p63/p73 network mediates chemosensitivity to
cisplatin in a biologically defined subset of primary breast
cancers. J Clin Invest. 117:1370–1380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Maas AM, Bretz AC, Mack E and Stiewe T:
Targeting p73 in cancer. Cancer Lett. Aug 22–2011.(Epub ahead of
print).
|
|
7.
|
Han S, Semba S, Abe T, Makino N, Furukawa
T, Fukushige S, Takahashi H, Sakurada A, Sato M, Shiiba K, Matsuno
S, et al: Infrequent somatic mutations of the p73 gene in various
human cancers. Eur J Surg Oncol. 25:194–198. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Corn PG, Kuerbitz SJ, van Noesel MM,
Esteller M, Compitello N, Baylin SB and Herman JG: Transcriptional
silencing of the p73 gene in acute lymphoblastic leukemia and
Burkitt’s lymphoma is associated with 5′CpG island methylation.
Cancer Res. 59:3352–3356. 1999.PubMed/NCBI
|
|
9.
|
Liu K, Zhan M and Zheng P: Loss of p73
expression in six non-small cell lung cancer cell lines is
associated with 5′ CpG island methylation. Exp and Mol Pathology.
84:59–63. 2008.PubMed/NCBI
|
|
10.
|
Peters UR, Tschan MP, Kreuzer KA,
Baskaynak G, Lass U, Tobler A, Fey MF and Schmidt CA: Distinct
expression patterns of the p53-homologue p73 in malignant and
normal hematopoiesis assessed by a novel real-time reverse
transcription-polymerase chain reaction assay and protein analysis.
Cancer Res. 59:4233–4236. 1999.
|
|
11.
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Biswas AK and Johnson DG: Transcriptional
and nontranscriptional functions of E2F1 in response to DNA damage.
Cancer Res. 72:13–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
He Y, Fan S and Jiang Y: Effects of p73
gene overexpression on apoptosis and chemosensitivity of human lung
adenocarcinoma cell line A549. Chinese J Cancer. 25:925–932.
2006.PubMed/NCBI
|
|
14.
|
Pei JH, Luo SQ, Zhong Y, Chen JH, Xiao HW
and Hu WX: The association between non-Hodgkin lymphoma and
methylation of p73. Tumour Biol. 32:1133–1138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Meyer G: p73: a complex gene for building
a complex brain. Cell Cycle. 10:1188–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Liu SS, Leung RC, Chan KY, Chiu PM, Cheung
AN, Tam KF, Ng TY, Wong LC and Ngan HY: p73 expression is
associated with the cellular radiosensitivity in cervical cancer
after radiotherapy. Clin Cancer Res. 10:3309–3316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Heller G, Zielinski CC and
Zöchbauer-Müller S: Lung cancer: from single-gene methylation to
methylome profiling. Cancer Metastasis Rev. 29:95–107. 2010.
View Article : Google Scholar : PubMed/NCBI
|
